ArticleBlood advances2022

INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia.

Giovanni Martinelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.